Gambaran Umum
DURECT Corporation, based in the United States, operates primarily within the pharmaceutical industry, focusing on the development of innovative drugs and therapies. The company's expertise centers on drug delivery technology and biological products designed to address unmet medical needs, particularly in areas of chronic conditions and acute events. Key projects include the development of DUR-928, a novel therapeutic candidate with potential applications in conditions such as alcoholic hepatitis, nonalcoholic steatohepatitis (NASH), and acute kidney injury. DURECT's portfolio also features advanced drug delivery systems that enhance the efficacy and safety of existing pharmaceutical compounds. Through strategic collaboration and proprietary technologies, DURECT aims to improve patient outcomes and provide value to healthcare providers and stakeholders in the biotech sector.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk DURECT Corporation per 2025 Jun 30 adalah 1.66 MM.
- Nilai operating income untuk DURECT Corporation per 2025 Jun 30 adalah -15.36 MM.
- Nilai net income untuk DURECT Corporation per 2025 Jun 30 adalah -3.48 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1.66 | -15.36 | -3.48 |
2025-03-31 | 1.86 | -16.75 | -4.91 |
2024-12-31 | 2.03 | -18.91 | -8.32 |
2024-09-30 | -0.22 | -23.52 | -17.07 |
2024-06-30 | -0.40 | -29.11 | -15.80 |
2024-03-31 | 1.03 | -34.96 | -23.28 |
2023-12-31 | 2.59 | -39.68 | -27.62 |
2023-09-30 | 9.19 | -42.13 | -36.65 |
2023-06-30 | 19.43 | -34.70 | -36.11 |
2023-03-31 | 19.42 | -35.74 | -36.48 |
2022-12-31 | 19.28 | -35.08 | -35.33 |
2022-09-30 | 23.27 | -30.10 | -31.87 |
2022-06-30 | 13.45 | -37.42 | -39.38 |
2022-03-31 | 13.68 | -34.99 | -36.97 |
2021-12-31 | 13.98 | -34.27 | -36.27 |
2021-09-30 | 8.89 | -36.07 | -24.90 |
2021-06-30 | 8.53 | -35.44 | -24.25 |
2021-03-31 | 30.73 | -12.44 | -0.77 |
2020-12-31 | 30.11 | -12.62 | -0.58 |
2020-09-30 | 34.10 | -9.06 | -9.17 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.16 | -0.16 |
2024-12-31 | -0.27 | -0.27 |
2024-09-30 | -0.56 | -0.66 |
2024-06-30 | -0.53 | -0.67 |
2024-03-31 | -0.83 | -0.97 |
2023-12-31 | -1.05 | -1.20 |
2023-09-30 | -1.49 | -1.53 |
2023-06-30 | -1.54 | -1.55 |
2023-03-31 | -1.58 | -1.60 |
2022-12-31 | -1.55 | -1.55 |
2022-09-30 | -1.40 | -1.40 |
2022-06-30 | -1.73 | -1.69 |
2022-03-31 | -1.62 | -1.59 |
2021-12-31 | -1.61 | -1.61 |
2021-09-30 | -1.14 | -1.10 |
2021-06-30 | -1.14 | -1.18 |
2021-03-31 | -0.04 | -0.07 |
2020-12-31 | -0.03 | -0.03 |
2020-09-30 | -0.47 | -0.53 |
2020-06-30 | -0.09 | -0.06 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk DURECT Corporation per 2025 Jun 30 adalah -13.96 MM.
- Nilai cash from investing activities untuk DURECT Corporation per 2025 Jun 30 adalah 17.53 MM.
- Nilai kas dari aktivitas pendanaan untuk DURECT Corporation per 2025 Jun 30 adalah -12.71 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -13.96 | 17.53 | -12.71 |
2025-03-31 | -15.86 | 19.43 | -14.85 |
2024-12-31 | -19.09 | 18.04 | -16.35 |
2024-09-30 | -21.89 | -1.00 | -7.00 |
2024-06-30 | -26.24 | 3.23 | 6.90 |
2024-03-31 | -31.92 | 2.87 | 9.00 |
2023-12-31 | -34.41 | -1.17 | 20.50 |
2023-09-30 | -34.50 | 1.34 | 21.75 |
2023-06-30 | -29.25 | 3.86 | 10.02 |
2023-03-31 | -29.98 | 9.77 | 10.07 |
2022-12-31 | -26.28 | 19.84 | 0.08 |
2022-09-30 | -28.98 | 23.75 | 0.21 |
2022-06-30 | -34.11 | 25.10 | 0.07 |
2022-03-31 | -32.16 | 24.56 | -0.51 |
2021-12-31 | -37.31 | 15.31 | 50.53 |
2021-09-30 | -34.58 | 20.49 | 50.83 |
2021-06-30 | -35.91 | 15.48 | 58.05 |
2021-03-31 | -36.55 | -4.43 | 65.95 |
2020-12-31 | -38.70 | 9.43 | 15.66 |
2020-09-30 | -26.35 | -13.78 | 19.07 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk DURECT Corporation pada 2025 Jun 30 adalah 3.65.
- p/tbv untuk DURECT Corporation pada 2025 Jun 30 adalah 7.45.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 3.65 | 7.45 | |
2025-03-31 | 2.59 | 3.62 | |
2024-12-31 | -1.55 | 21.68 | -5.33 |
2024-09-30 | -2.57 | 8.07 | -35.92 |
2024-06-30 | -1.82 | 5.10 | 19.88 |
2024-03-31 | -1.45 | 2.70 | 4.64 |
2023-12-31 | -0.47 | 1.19 | 2.09 |
2023-09-30 | -1.92 | 12.60 | -103.55 |
2023-06-30 | -3.30 | 7.85 | 13.14 |
2023-03-31 | -3.17 | 4.49 | |
2022-12-31 | 2.29 | 2.78 | |
2022-09-30 | 3.60 | 4.32 | |
2022-06-30 | 2.27 | 2.61 | |
2022-03-31 | -4.21 | 2.64 | 2.96 |
2021-12-31 | -8.86 | 3.45 | 3.81 |
2021-09-30 | -12.10 | 3.99 | 4.36 |
2021-06-30 | |||
2021-03-31 | -140.29 | 1.32 | 1.43 |
2020-12-31 | -165.73 | 2.40 | 2.84 |
2020-09-30 | -10.50 | 2.77 | 3.40 |
2020-06-30 | -51.65 | 2.60 | 3.16 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk DURECT Corporation pada 2025 Jun 30 adalah -1.28.
- EBIT (3 tahun) / EV untuk DURECT Corporation pada 2025 Jun 30 adalah -1.92.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -1.28 | -1.92 |
2025-03-31 | -0.74 | -1.07 |
2024-12-31 | -0.61 | -0.96 |
2024-09-30 | -0.42 | -0.75 |
2024-06-30 | -0.62 | -0.85 |
2024-03-31 | -0.98 | -1.17 |
2023-12-31 | 11.81 | 11.45 |
2023-09-30 | -0.62 | -0.65 |
2023-06-30 | -0.31 | -0.32 |
2023-03-31 | -0.39 | -0.32 |
2022-12-31 | -0.63 | -0.53 |
2022-09-30 | -0.37 | -0.28 |
2022-06-30 | -0.46 | -0.32 |
2022-03-31 | -0.29 | -0.20 |
2021-12-31 | -0.20 | -0.13 |
2021-09-30 | -0.15 | -0.09 |
2021-06-30 | ||
2021-03-31 | -0.20 | -0.29 |
2020-12-31 | -0.15 | -0.21 |
2020-09-30 | -0.11 | -0.15 |
2020-06-30 | -0.03 | -0.10 |
Efektivitas Manajemen
- roa untuk DURECT Corporation pada 2025 Jun 30 adalah -0.16.
- roe untuk DURECT Corporation pada 2025 Jun 30 adalah -0.98.
- roic untuk DURECT Corporation pada 2025 Jun 30 adalah -0.67.
- croic untuk DURECT Corporation pada 2025 Jun 30 adalah -1.54.
- ocroic untuk DURECT Corporation pada 2025 Jun 30 adalah -2.16.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.16 | -0.98 | -0.67 | -1.54 | -2.16 |
2025-03-31 | -0.22 | -0.95 | -0.35 | -1.34 | -0.98 |
2024-12-31 | -0.38 | -1.15 | -1.14 | -2.00 | -1.46 |
2024-09-30 | -0.29 | -1.10 | -0.75 | -0.76 | -1.24 |
2024-06-30 | -0.40 | -1.52 | -0.87 | -0.75 | -1.20 |
2024-03-31 | -0.46 | -1.11 | -0.78 | -0.32 | -0.97 |
2023-12-31 | -0.54 | -1.05 | -0.98 | -0.30 | -0.92 |
2023-09-30 | -0.52 | -0.98 | -1.27 | -0.54 | -1.03 |
2023-06-30 | -0.52 | -0.99 | -0.81 | -0.34 | -0.65 |
2023-03-31 | -0.44 | -0.74 | -0.95 | -0.26 | -0.78 |
2022-12-31 | -0.33 | -0.50 | -0.55 | -0.09 | -0.50 |
2022-09-30 | -0.40 | -0.62 | -0.55 | -0.09 | -0.50 |
2022-06-30 | -0.35 | -0.50 | -0.65 | -0.15 | -0.56 |
2022-03-31 | -0.31 | -0.44 | -0.52 | -0.11 | -0.45 |
2021-12-31 | -0.33 | -0.62 | -0.44 | 0.35 | -0.39 |
2021-09-30 | -0.35 | -0.70 | -0.28 | 0.42 | -0.37 |
2021-06-30 | -0.33 | -0.67 | -0.25 | 0.38 | -0.37 |
2021-03-31 | -0.01 | -0.05 | -0.01 | 0.23 | -0.34 |
2020-12-31 | -0.01 | -0.03 | -0.01 | -0.21 | -0.59 |
2020-09-30 | -0.10 | -0.42 | -0.15 | -0.35 | -0.43 |
2020-06-30 | -0.03 | -0.08 | -0.03 | -0.29 | 0.02 |
Gross Margins
- marjin kotor untuk DURECT Corporation pada 2025 Jun 30 adalah 1.76.
- marjin bersih untuk DURECT Corporation pada 2025 Jun 30 adalah -2.65.
- marjin operasi untuk DURECT Corporation pada 2025 Jun 30 adalah -9.02.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 1.76 | -2.65 | -9.02 |
2025-03-31 | -4.15 | -3.88 | -9.09 |
2024-12-31 | -0.86 | -1.99 | -2.25 |
2024-09-30 | -1.47 | -1.88 | -2.96 |
2024-06-30 | -2.18 | -2.80 | -3.80 |
2024-03-31 | 0.80 | -3.23 | -4.31 |
2023-12-31 | -2.84 | -3.99 | -4.58 |
2023-09-30 | -0.96 | -1.86 | -1.79 |
2023-06-30 | 0.83 | -1.86 | -1.79 |
2023-03-31 | -0.99 | -1.88 | -1.84 |
2022-12-31 | -0.60 | -1.37 | -1.29 |
2022-09-30 | -1.63 | -1.37 | -1.29 |
2022-06-30 | -1.49 | -2.93 | -2.78 |
2022-03-31 | -1.42 | -2.70 | -2.56 |
2021-12-31 | -2.56 | -2.59 | -2.45 |
2021-09-30 | -2.57 | -2.80 | -4.06 |
2021-06-30 | -2.57 | -2.84 | -4.15 |
2021-03-31 | 0.04 | -0.02 | -0.40 |
2020-12-31 | 0.03 | -0.02 | -0.42 |
2020-09-30 | 0.13 | -0.26 | -0.26 |
2020-06-30 | 0.28 | -0.04 | -0.05 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1082038 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |